Publications by authors named "Kara Sapp"
Article Synopsis
- People who use drugs (PWUD) face significant risks of hepatitis B (HBV) and delta (HDV) viruses, but awareness of these risks is low among both the affected communities and healthcare providers.
- The study utilized surveys and interviews in Philadelphia to uncover barriers to HBV and HDV prevention, diagnosis, and care, revealing confusion over insurance and patient hesitancy as key challenges.
- Findings indicated a widespread lack of knowledge about HBV and HDV, suggesting that educational campaigns should be stigma-free, relatable, and empowering to effectively reach and inform the PWUD community.
The prevalence of hepatitis B and delta viruses (HBV/HDV) among people who use drugs (PWUD) remains largely unknown. In the context of one Philadelphia-based harm reduction organization (HRO), this study aimed to assess HBV/HDV prevalence and facilitate linkage to care. Participants completed a demographic HBV/HDV risk factor survey and were screened for HBV and reflexively for HDV if positive for HBV surface antigen or isolated core antibody.
View Article and Find Full Text PDF